Atlas Trials

The Immune Response Corporation

3 clinical trials · Sponsor

Sort:Newest firstOldest first

◉ Watch The Immune Response Corporation

RecordFirmDate
An Expanded Access Open-Label, Compassionate Use Protocol of Remune in HIV-1-Infected Adults With CD4 Count Less Than 300 Cells/Ml (NCT00002172)The Immune Response Corporation
A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega (NCT00002359)The Immune Response Corporation
An Expanded Access Open Label Protocol of Remune (HIV-1 Immunogen) in HIV-1-Infected Adults With CD4 Count 550 Cells /Ml and Greater. (NCT00002173)The Immune Response Corporation

Track The Immune Response Corporation automatically

Every clearance here is in the API, with alerts when new ones post.